Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oncternal Therapeutics Inc. buy bundfuture

Start price
€2.13
26.12.21 / 50%
Target price
-
26.12.22
Performance (%)
-14.96%
End price
€1.81
09.01.22
Summary
This prediction ended on 09.01.22 with a price of €1.81. The prediction for Oncternal Therapeutics Inc. disappointed with a performance of -14.96%. bundfuture has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Oncternal Therapeutics Inc. - - -
iShares Core DAX® 0.961% -2.210% 12.839%
iShares Nasdaq 100 2.626% -1.918% 38.498%
iShares Nikkei 225® 0.217% -7.216% 19.425%
iShares S&P 500 1.540% -1.858% 27.801%

Comments by bundfuture for this prediction

In the thread Oncternal Therapeutics Inc. diskutieren

Buy Oncternal Therapeutics Inc.

In the thread Trading Oncternal Therapeutics Inc.
Prediction Buy
Perf. (%) -14.96%
Target price
Change
Ends at 26.12.22

Buy beendet

Stopped prediction by bundfuture for Oncternal Therapeutics Inc.

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
17.11.21
-
17.11.22
-18.82%
28.11.21

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.17
31.10.21
-
31.10.22
8.32%
14.11.21

Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.15
09.11.20
€4.55
-26.60%
15.11.20